Skip to main content
KoBioLabs, Inc. logo

KoBioLabs, Inc. — Investor Relations & Filings

Ticker · 348150 ISIN · KR7348150004 KO Manufacturing
Open in API
Filings indexed 174 across all filing types
Latest filing 2022-12-29 Director's Dealing
Country KR South Korea
Listing KO 348150

About KoBioLabs, Inc.

http://kobiolabs.com/en/

KoBioLabs, Inc. is a biotechnology company that develops innovative microbiome-based therapeutics. The company utilizes its proprietary Smartiome® platform, an integrated system for discovering novel drug candidates that employs AI-driven multi-omics analysis and a comprehensive microbiome library with a reverse-translation approach. KoBioLabs is focused on creating a pipeline of new drugs to treat a range of immune, metabolic, and brain disorders. The company also applies advanced technologies, including a microbe-based drug delivery system (mDDS) and biofoundry techniques, to enhance the efficacy of its treatments and address unmet medical needs.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory disclosure for insider trading or changes in share ownership by company directors/executives. In the provided classification schema, this corresponds to 'Director's Dealing' (DIRS).
2022-12-29 Korean
투자판단관련주요경영사항(마이크로바이옴 신약 후보물질 중국 등 지역(중국, 홍콩, 마카오, 대만)기술이전 계약 관련 계약금 수령)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Major Management Matter' (투자판단 관련 주요경영사항). It details the receipt of a milestone payment (contract fee) related to a previously announced technology transfer agreement. Since this is a specific regulatory disclosure of a material event (receipt of funds) and does not fit into categories like M&A, dividends, or board changes, it is classified as a general Regulatory Filing (RNS).
2022-12-20 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the closure of the shareholder register to determine eligibility for the upcoming Annual General Meeting (AGM). It does not contain the full AGM materials or the meeting results, but rather serves as a formal notice of the record date and register closure period. Given its nature as a regulatory notification regarding corporate governance procedures, it fits best under the RNS (Regulatory Filings) category.
2022-12-12 Korean
기타경영사항(자율공시)(특허권 취득)(락토바실러스 플란타럼 KBL396 균주 및 그 용도-미국)
Regulatory Filings Classification · 100% confidence The document is a voluntary disclosure (자율공시) filed by GoBioLab regarding the acquisition of a patent in the United States. It details the patent name, its application, and the date of acquisition. Since this is a specific corporate announcement regarding a business development (patent acquisition) that does not fit into financial reporting, M&A, or other specific categories, it falls under the general regulatory filing category.
2022-12-05 Korean
기타경영사항(자율공시)(특허권 취득(아커만시아 뮤시니필라 균주 및 이의 용도))
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (KoBioLabs) regarding the acquisition of a patent. It is categorized as a 'voluntary disclosure' (자율공시) of a business event. Since it does not fit into specific categories like financial reports, M&A, or director dealings, it falls under the general regulatory filing category.
2022-11-24 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for KoBioLabs, covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial information, business operations, management discussions, and shareholding structures, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.